| |
| |
|
| Insider
Information: |
Doberstein Stephen K |
| Relationship: |
Director |
| City: |
San Carlos |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
107,668 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$169,039 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
107,668 |
|
|
| Total
Value |
$169,039 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Nektar Therapeutics |
NKTR |
SVP & Chief Scientific... |
2019-09-05 |
107,668 |
2016-02-16 |
0 |
Premium* |
|
|
Dicerna Pharmaceuticals Inc |
DRNA |
Director |
2021-12-28 |
0 |
2021-06-03 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| DRNA |
Dicerna Pharmaceuticals I... |
Director |
– • – |
2021-12-28 |
4 |
D |
$38.25 |
$127,487 |
D/D |
(3,333) |
0 |
0 |
- |
|
| DRNA |
Dicerna Pharmaceuticals I... |
Director |
– • – |
2021-06-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,333 |
3,333 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
SVP & Chief Scientific Officer |
• – – |
2019-09-05 |
4 |
B |
$17.28 |
$259,200 |
D/D |
15,000 |
107,668 |
2.74 |
- |
|
| NKTR |
Nektar Therapeutics |
SVP & Chief Scientific Officer |
• – – |
2019-08-16 |
4 |
S |
$18.15 |
$58,897 |
D/D |
(3,245) |
92,668 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
SVP & Chief Scientific Officer |
• – – |
2019-05-16 |
4 |
S |
$31.37 |
$108,572 |
D/D |
(3,461) |
95,913 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
SVP & Chief Scientific Officer |
• – – |
2019-02-19 |
4 |
S |
$42.39 |
$140,311 |
D/D |
(3,310) |
99,374 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
SVP & Chief Scientific Officer |
• – – |
2018-12-14 |
4 |
A |
$0.00 |
$0 |
D/D |
23,950 |
102,684 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
SVP & Chief Scientific Officer |
• – – |
2018-11-16 |
4 |
S |
$38.25 |
$173,043 |
D/D |
(4,524) |
78,734 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
SVP & Chief Scientific Officer |
• – – |
2018-08-16 |
4 |
D |
$58.40 |
$391,338 |
D/D |
(6,701) |
83,258 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
SVP & Chief Scientific Officer |
• – – |
2018-08-15 |
4 |
A |
$0.00 |
$0 |
D/D |
26,000 |
89,959 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
SVP & Chief Scientific Officer |
• – – |
2018-05-16 |
4 |
S |
$83.39 |
$286,445 |
D/D |
(3,435) |
63,959 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
SVP & Chief Scientific Officer |
• – – |
2018-04-09 |
4 |
AS |
$96.13 |
$4,758,435 |
D/D |
(49,500) |
67,394 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
SVP & Chief Scientific Officer |
• – – |
2018-04-09 |
4 |
OE |
$7.21 |
$356,895 |
D/D |
49,500 |
116,894 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
SVP & Chief Scientific Officer |
• – – |
2018-04-06 |
4 |
AS |
$91.69 |
$10,131,745 |
D/D |
(110,500) |
67,394 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
SVP & Chief Scientific Officer |
• – – |
2018-04-06 |
4 |
OE |
$7.21 |
$1,005,505 |
D/D |
110,500 |
177,894 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
SVP & Chief Scientific Officer |
• – – |
2018-02-16 |
4 |
S |
$82.94 |
$201,212 |
D/D |
(2,426) |
67,394 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
SVP & Chief Scientific Officer |
• – – |
2017-12-15 |
4 |
A |
$0.00 |
$0 |
D/D |
26,000 |
69,820 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
SVP & Chief Scientific Officer |
• – – |
2017-11-16 |
4 |
D |
$44.23 |
$211,508 |
D/D |
(4,782) |
43,820 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
SVP & Chief Scientific Officer |
• – – |
2017-11-15 |
4 |
A |
$0.00 |
$0 |
D/D |
17,500 |
48,602 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
SVP & Chief Scientific Officer |
• – – |
2017-11-08 |
4 |
AS |
$30.09 |
$9,027,000 |
D/D |
(300,000) |
31,102 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
SVP & Chief Scientific Officer |
• – – |
2017-11-08 |
4 |
OE |
$9.53 |
$2,859,000 |
D/D |
300,000 |
331,102 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
SVP & Chief Scientific Officer |
• – – |
2017-11-07 |
4 |
AS |
$25.78 |
$1,944,044 |
D/D |
(75,409) |
31,102 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
SVP & Chief Scientific Officer |
• – – |
2017-11-07 |
4 |
OE |
$9.53 |
$718,648 |
D/D |
75,409 |
106,511 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
SVP & Chief Scientific Officer |
• – – |
2017-11-06 |
4 |
AS |
$24.98 |
$522,432 |
D/D |
(20,914) |
31,102 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
SVP & Chief Scientific Officer |
• – – |
2017-11-06 |
4 |
OE |
$9.53 |
$199,310 |
D/D |
20,914 |
52,016 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
